Request Deal Involvement
Novartis completed the acquisition of Vedere Bio from Atlas Venture and Mission BioCapital for $280m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Goodwin Procter
or
Principals
target
VEDERE BIO INC
bidder
NOVARTIS AG
vendor
MISSION BIOCAPITAL
vendor
ATLAS VENTURE LP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite